Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Duke Clinical Research Institute, Durham, North Carolina.
JAMA Cardiol. 2024 Jul 1;9(7):667-672. doi: 10.1001/jamacardio.2024.1108.
Kidney health has received increasing focus as part of comprehensive heart failure (HF) treatment efforts. However, the occurrence of clinically relevant kidney outcomes in contemporary populations with HF has not been well studied.
To examine rates of incident dialysis and acute kidney injury (AKI) among Medicare beneficiaries after HF hospitalization.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study evaluated adults aged 65 years or older who were hospitalized for HF across 372 sites in the Get With The Guidelines-Heart Failure registry in the US between January 1, 2014, and December 31, 2018. Patients younger than 65 years or requiring dialysis either during or prior to hospitalization were excluded. Data were analyzed from May 4, 2021, to March 8, 2024.
The primary outcome was inpatient dialysis initiation in the year after HF hospitalization and was ascertained via linkage with Medicare claims data. Other all-cause and cause-specific hospitalizations were also evaluated. The covariate-adjusted association between discharge estimated glomerular filtration rate (eGFR) and 1-year postdischarge outcomes was examined using Cox proportional hazards regression models.
Overall, among 85 298 patients included in the analysis (mean [SD] age, 80 [9] years; 53% women) mean (SD) left ventricular ejection fraction was 47% (16%) and mean (SD) eGFR was 53 (29) mL/min per 1.73 m2; 54 010 (63%) had an eGFR less than 60 mL/min per 1.73 m2. By 1 year after HF hospitalization, 6% had progressed to dialysis, 7% had progressed to dialysis or end-stage kidney disease, and 7% had been readmitted for AKI. Incident dialysis increased steeply with lower discharge eGFR category: compared with patients with an eGFR of 60 mL/min per 1.73 m2 or more, individuals with an eGFR of 45 to less than 60 and of less than 30 mL/min per 1.73 m2 had higher rates of dialysis readmission (45 to <60: adjusted hazard ratio [AHR], 2.16 [95% CI, 1.86-2.51]; <30: AHR, 28.46 [95% CI, 25.25-32.08]). Lower discharge eGFR (per 10 mL/min per 1.73 m2 decrease) was independently associated with a higher rate of readmission for dialysis (AHR, 2.23; 95% CI, 2.14-2.32), dialysis or end-stage kidney disease (AHR, 2.34; 95% CI, 2.24-2.44), and AKI (AHR, 1.25; 95% CI, 1.23-1.27), with similar findings for all-cause mortality, all-cause readmission, and HF readmission. Baseline left ventricular ejection fraction did not modify the covariate-adjusted association between lower discharge eGFR and kidney outcomes.
In this study, older adults with HF had substantial risk of kidney complications, with an estimated 6% progressing to dialysis in the year after HF hospitalization. These findings emphasize the need for health care approaches prioritizing kidney health in this high-risk population.
随着心力衰竭(HF)综合治疗工作的推进,肾脏健康受到了越来越多的关注。然而,HF 患者的临床相关肾脏结局在当代人群中的发生情况尚未得到很好的研究。
研究美国 Get With The Guidelines-Heart Failure 注册中心 372 个地点中 HF 住院患者在出院后发生透析和急性肾损伤(AKI)的发生率。
设计、地点和参与者:这项回顾性队列研究评估了年龄在 65 岁或以上、在 2014 年 1 月 1 日至 2018 年 12 月 31 日期间因 HF 住院的美国成年人。年龄小于 65 岁或在住院期间或之前需要透析的患者被排除在外。数据于 2021 年 5 月 4 日至 2024 年 3 月 8 日进行分析。
主要结局是 HF 出院后一年内开始住院透析,通过与医疗保险索赔数据进行关联来确定。还评估了其他全因和特定病因的住院治疗情况。使用 Cox 比例风险回归模型检查出院时估计肾小球滤过率(eGFR)与 1 年后的出院结局之间的协变量调整关联。
在纳入分析的 85298 名患者中(平均[标准差]年龄为 80[9]岁;53%为女性),平均(标准差)左心室射血分数为 47%(16%),平均(标准差)eGFR 为 53(29)mL/min/1.73m2;54010 名患者(63%)的 eGFR 小于 60mL/min/1.73m2。HF 出院后 1 年内,有 6%进展为透析,7%进展为透析或终末期肾病,7%因 AKI 再次入院。新发生的透析与较低的出院 eGFR 类别呈显著增加趋势:与 eGFR 为 60mL/min/1.73m2 或更高的患者相比,eGFR 为 45 至<60 和<30mL/min/1.73m2 的患者透析再入院的比例更高(45 至<60:调整后的危险比[HR],2.16[95%CI,1.86-2.51];<30:HR,28.46[95%CI,25.25-32.08])。较低的出院 eGFR(每降低 10mL/min/1.73m2)与透析再入院率较高独立相关(HR,2.23;95%CI,2.14-2.32)、透析或终末期肾病(HR,2.34;95%CI,2.24-2.44)和 AKI(HR,1.25;95%CI,1.23-1.27),全因死亡率、全因再入院率和 HF 再入院率也有类似的发现。基线左心室射血分数不能改变出院时 eGFR 与肾脏结局之间的协变量调整关联。
在这项研究中,HF 的老年患者存在严重的肾脏并发症风险,HF 出院后 1 年内有估计 6%的患者进展为透析。这些发现强调了在这一高危人群中优先考虑肾脏健康的医疗保健方法的必要性。